Association of  P73  polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis

Xianghua Liang; Bingxiang Chen; Jianxin Zhong

doi:10.18632/oncotarget.18164

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis

Xianghua Liang _, Bingxiang Chen and Jianxin Zhong

PDF | HTML | How to cite

Oncotarget. 2017; 8:57409-57413. https://doi.org/10.18632/oncotarget.18164

Metrics: PDF 1760 views | HTML 1652 views | ?

Abstract

Xianghua Liang1, Bingxiang Chen1 and Jianxin Zhong2

1Department of Gynecology and Obstetrics, Qidong People's Hospital, Jiangsu, China

2Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Jiangsu, China

Correspondence to:

Xianghua Liang, email: [email protected]

Keywords: P73 gene, cervical cancer, meta analysis

Received: March 31, 2017 Accepted: May 09, 2017 Published: May 24, 2017

ABSTRACT

Objective: The relation between P73 gene polymorphism and cervical cancer has not been determined. At present, we utilized a meta-analysis method to elucidate the association between P73 and cervical cancer.

Results: The present study included 635 patients with cervical cancer and 998 cancer-free control subjects. Using meta-analysis, we found a significant association of P73 genetic polymorphism with cervical cancer in a recessive model [OR = 0.91, 95% CI: 0.84−0.98; P = 0.02.]. However, this association was not find in a dominant model [OR = 0.76, 95% CI (0.45−1.27); P = 0.29], in a co-dominant model [OR = 1.01; 95% CI: 0.98–1.04, P = 0.56] or in an allelic model [OR = 0.97, 95% CI: 0.93−1.00; P = 0.09].

Materials and Methods: To further evaluate the relation between the P73 gene polymorphism and cervical cancer, we selected 5 case-control studies related to P73 gene polymorphism and cervical cancer by searching CNKI, VIP, WanFang, PubMed and EMbase database. We utilized Q-test and I² test to test the heterogeneity between each study. The fixed effects model was utilized to calculate the odds ratio (OR) and its 95% confidence interval.

Conclusions: Our results suggest that P73 gene polymorphism was associated with the risk of cervical cancer. However, our conclusion still requires large sample size of case-control studies or cohort studies to further confirm this result.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18164

Publication Alerts

Meta-Analysis:

Association of P73 polymorphisms with susceptibilities of cervical carcinoma: a meta-analysis

Abstract